Washington — Dr. Anthony Fauci, one of the nation’s leading infectious disease experts, believes that by early 2021, the U.S. will have “a couple of hundred million doses” of a vaccine for the coronavirus. In an interview with the Journal of the American Medical Association on Tuesday, Fauci said there are four or five trials underway for vaccine candidates, and …

Washington — Dr. Anthony Fauci, one of the nation’s leading infectious disease experts, believes that by early 2021, the U.S. will have “a couple of hundred million doses” of a vaccine for the coronavirus. In an interview with the Journal of the American Medical Association on Tuesday, Fauci said there are four or five trials underway for vaccine candidates, and …

SARS-CoV-2, the virus that causes COVID-19, enlists the help of two enzymes on the surface of human cells in order to invade them. A new study suggests that a compound that inhibits both enzymes could make a highly effective treatment. Share on PinterestNew research finds that a drug could keep the new coronavirus from entering healthy cells. When disease-causing viruses …

Dr. Anthony Fauci speaking during the U.S. Senate committee on Health, Education, Labor and Pensions hearing on May 12th, 2020. CNBC White House health advisor Dr. Anthony Fauci said he worries about the “durability” of a potential coronavirus vaccine, saying there’s a chance it may not provide long-term immunity. If Covid-19 acts like other coronaviruses, “it likely isn’t going to …

Enlarge Aurich Lawson / Getty The Lancet medical journal on Tuesday issued an “expression of concern” over the validity of a recent study suggesting that the anti-malarial drugs chloroquine and hydroxychloroquine raise the risk of death and heart complications in hospitalized COVID-19 patients. More than a hundred researchers have raised questions and skepticism about the data and analysis, even as …

WASHINGTON — Americans returning from China landed at U.S. airports by the thousands in early February, potential carriers of a deadly virus who had been diverted to a handful of cities for screening by the Centers for Disease Control and Prevention. Their arrival prompted a frantic scramble by local and state officials to press the travelers to self-quarantine, and to …

<!– –> A hydroxychloroquine study is being audited. AP Photo/John Locher By Kelly Servick, Martin EnserinkJun. 2, 2020 , 7:55 PM Science‘s COVID-19 reporting is supported by the Pulitzer Center. On its face, it was a major finding: Antimalarial drugs touted by the White House as possible COVID-19 treatments looked to be not just ineffective, but downright deadly. A study published …

The announcement on May 18 that a candidate vaccine for the coronavirus appeared to create an immune response in a handful of people sent spirits, and the stock market, soaring. President Trump has raised the tantalizing possibility that the COVID-19 pandemic could be ended by a vaccine as soon as the start of next year.  But infectious disease specialists and …

Researchers may have finally figured out why it’s been so difficult to tell where the coronavirus SARS-CoV-2 — which causes COVID-19 — came from within the animal kingdom. While most evidence suggests that the virus spread among bats before infecting people, a genetic analysis of it never identified a perfect match among known bat diseases. Now, scientists think that’s because …

Concerns are mounting about studies in two influential medical journals on drugs used in people with coronavirus, including one that led multiple countries to stop testing a malaria pill. The New England Journal of Medicine issued an “expression of concern” Tuesday on a study it published May 1 that suggested widely used blood pressure medicines were not raising the risk …